How is your pharmacy or practice navigating medication availability challenges today
Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market
The health implications of PCOS extend well beyond reproductive concerns
And again, you know, relapse is the nature of recovery
Bariatric surgery typically leads to greater overall and more sustained weight loss
This could be because those with obesity had a more difficult time obtaining insurance benefits for these expensive medications